Services βΎ
Consulting
Research Methodology
Case Studies
Reports βΎ
Resources βΎ
Blogs
Whitepapers
Press Releases
Thought Articles
About Us
Client Portal
π
πΊπΈ
English
βΌ
β°
Home
βΊ
Healthcare
βΊ
Biotechnology
βΊ
Personalized Cancer Immunotherapy Market
Personalized Cancer Immunotherapy Market - Strategic Insights and Forecasts (2026-2031)
Personalized immunotherapy market trends driven by AI-assisted treatment design and combination therapies.
π₯ Download Free Sample
π¬ Speak to Analyst
$3,950
Single User License
Access Full Insights
Market Size
See Report
by 2031
CAGR
Ask for a sample
2026-2031
Base Year
2025
Forecast Period
2026-2031
Projection
Report Overview
Segmentation
Table of Contents
Customize Report
Market Segmentation
By Therapy Type
Immune Checkpoint Inhibitors
CAR-T Cell Therapy
T-Cell Receptor (TCR) Therapy
Tumor-Infiltrating Lymphocytes (TIL) Therapy
Cancer Vaccines (Personalized / Neoantigen-Based)
Monoclonal Antibodies
Cytokine-Based Therapies
By Cancer Type
Lung Cancer
Breast Cancer
Colorectal Cancer
Melanoma
Prostate Cancer
Hematological Malignancies
Others
By End User
Hospitals
Cancer Treatment Centers
Research Institutes
Specialty Clinics
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others
REPORT DETAILS
Report ID:
KSI-008429
Published:
Mar 2026
Pages:
165
Format:
PDF, Excel, PPT, Dashboard
π₯ Download Sample
π Speak to Analyst
π§ Request Customization
Need Assistance?
Our research team is available to answer your questions.
Contact Us